R. Fleischmann

发表论文 438 篇 · 总被引 30424 次 · h-index 77

代表论文

Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis. (2022 · New England Journal of Medicine · 被引 1302)
Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE study (2022 · RMD Open · 被引 90)
Olokizumab versus Placebo or Adalimumab in Rheumatoid Arthritis. (2022 · New England Journal of Medicine · 被引 54)
Safety profile of upadacitinib in patients at risk of cardiovascular disease: integrated post hoc analysis of the SELECT phase III rheumatoid arthritis clinical programme (2023 · Annals of the Rheumatic Diseases · 被引 46)
Olokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necrosis factor inhibitor therapy: efficacy and safety results of a randomised controlled phase III study (2022 · Annals of the Rheumatic Diseases · 被引 40)
Anti-GM-CSF otilimab versus sarilumab or placebo in patients with rheumatoid arthritis and inadequate response to targeted therapies: a phase III randomised trial (contRAst 3) (2023 · Annals of the Rheumatic Diseases · 被引 37)